Trial intelligence / Profile preview

Paclitaxel, Carboplatin, 5-FU and Radiotherapy Followed by Surgery in Esophageal Cancer

NCT00006472Phase 2Terminated

Sponsor
MedStar Health Research Institute
Start
Jan 2000
Primary completion
Nov 2001
Modality
DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin, fluorouracil in esophageal cancer, sponsored by MedStar Health Research Institute. Started Jan 2000; status: terminated.

02

Drugs

Paclitaxel Micelles for Injectioncarboplatinfluorouracil
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00006472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call